OTCMKTS:AVCTF Avacta Group (AVCTF) Stock Price, News & Analysis $0.85 0.00 (0.00%) As of 10/7/2026 12:09 PM Eastern Add Compare Share Share Stock Analysis Stock AnalysisChartNews and Trends About Avacta Group Stock (OTCMKTS:AVCTF) View Price History Chart DataSkip Price History Chart 1 Day 5 Days 30 Days 90 Days 1 Year Advanced 1 Day 1 Day 5 Days 30 Days 90 Days 1 Year Advanced Show volume Show extended hours Get Avacta Group alerts:Sign Up Key Stats Today's Range$0.85▼$0.8550-Day Range$0.85▼$1.0552-Week Range$0.74▼$1.23Volume100 shsAverage Volume22,464 shsMarket CapitalizationN/AP/E RatioN/ADividend YieldN/APrice TargetN/AConsensus RatingN/A Company Overview Avacta Group plc is a United Kingdom-based life sciences company focused on developing targeted cancer treatments. Its principal technology platform, pre|CISION, is designed to activate medicines selectively within the tumor microenvironment, with the goal of improving treatment effectiveness while reducing exposure to healthy tissue. The company’s lead clinical program is AVA6000, a tumor-activated form of doxorubicin being investigated for the treatment of solid tumors, including soft-tissue sarcoma. Avacta is also developing additional pre|CISION-based therapeutic candidates and has used its Affimer biologics platform to support the discovery and development of engineered binding proteins for therapeutic applications. Avacta was established in 2003 and has historically operated across therapeutics and diagnostics, including collaborations and services for pharmaceutical, biotechnology and diagnostic companies. The group is headquartered in the United Kingdom and works with international commercial and research partners. Its shares trade on the London Stock Exchange, with the company also represented in the U.S. over-the-counter market under the symbol AVCTF.AI Generated. May Contain Errors. Read More Receive AVCTF Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Avacta Group and its competitors with MarketBeat's FREE daily newsletter. Submit View SMS TermsSMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. AVCTF Stock News HeadlinesAvacta Group (OTCMKTS:AVCTF) Shares Down 9% - Here's WhyOctober 8 at 2:01 AM | americanbankingnews.comAvacta Group Plc Reports Earnings Results for the Half Year Ended June 30, 2026September 30, 2026 | marketscreener.comMCODE RED: AI Meltdown Imminent?After correctly predicting the 2008 and 2020 stock market meltdowns, I believe this AI company is about to trigger the next crash. The research firm Bernstein Research said this AI company has the power to crash the global economy for a decade, the CEO just issued a CODE RED in an internal memo warning employees they're dealing with a critical situation, and another company executive even implied they might need a government bailout. The last time I saw something like this was in 2008 when I predicted a stock market meltdown just three weeks before Lehman went under.October 8 at 1:00 AM | Paradigm Press (Ad)Avacta H1 Loss Widens As AVA6103 Advances Toward 2027 DataSeptember 30, 2026 | rttnews.comAvacta sospende le negoziazioni per avviare un aumento di capitaleSeptember 30, 2026 | it.investing.comAvacta Group plc: Interim Results for the Six Months to June 30, 2026, and Business UpdateSeptember 30, 2026 | markets.businessinsider.comLa piattaforma pre|CISION di Avacta vince un premio R&S nel settore farmaceutico UKSeptember 25, 2026 | it.investing.comAvacta Group plc: The FOCUS-01 Clinical Trial Design and Preclinical Data Further Demonstrate the Potential of AVA6103 at AACR Conference on Pancreatic CancerSeptember 25, 2026 | finance.yahoo.comSee More Headlines AVCTF Stock Analysis - Frequently Asked Questions How have AVCTF shares performed this year? Avacta Group's stock was trading at $0.7780 on January 1st, 2026. Since then, AVCTF stock has increased by 9.7% and is now trading at $0.8535. How do I buy shares of Avacta Group? Shares of AVCTF stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Industry, Sector and Symbol Stock ExchangeOTCMKTS SectorHealthcare Industry Biotechnology Sub-IndustryBiotechnology Current SymbolOTCMKTS:AVCTF CIKN/A Webwww.avacta.com Phone44.1904.21.7070FaxN/AEmployees120Year FoundedN/AProfitability EPS (Trailing Twelve Months)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/A Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AMiscellaneous Outstanding SharesN/AFree FloatN/AMarket CapN/A OptionableNot Optionable BetaN/A 7 Stocks That Could Lead the Next Market BoomTesla, Nvidia, and Google helped shape the last era of market growth, but the next wave could come from a new group of companies. Inside this report, you’ll find 7 stocks that could play a major role in the next tech-driven market boom.Get This Free Report This page (OTCMKTS:AVCTF) was last updated on 10/8/2026 by MarketBeat.com Staff. From Our PartnersNNVC Is Heading Into a Big MomentNanoViricides (NYSE American: NNVC) is moving NV-387 into a Phase II trial for Ebola in the Democratic Republi...Equiscreen | SponsoredThese gold assets are priced for $1,800 gold [it's over $4,000]Gold's major miners are generating record free cash flow, with margins as high as 75 percent even after gold's...Golden Portfolio | SponsoredInside a Former Merrill Lynch Advisor's Income PlaybookA former Merrill Lynch and Vanguard advisor spent 25 years watching one weekly options play generate consisten...Base Camp Trading | SponsoredTrump's New DollarPorter Stansberry says President Trump has signed an executive order initiating what he calls a full U.S. doll...Porter & Company | SponsoredCODE RED: AI Meltdown Imminent?After correctly predicting the 2008 and 2020 stock market meltdowns, I believe this AI company is about to tri...Paradigm Press | SponsoredElon Warns "America Will Go Bankrupt". Trump's Plan Inside.National debt just crossed 40 trillion dollars, and Elon Musk says America is 1,000% going to go bankrupt with...American Hartford Gold | SponsoredA simple options setup that cuts through the noiseIan Cooper says most options traders overcomplicate the process, juggling countless indicators, strategies, an...TradeWins | SponsoredA dividend every week of the yearMost dividend stocks pay quarterly, leaving long stretches of silence between paydays. For investors covering ...Market Savvy | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Avacta Group Plc Please log in to your account or sign up in order to add this asset to your watchlist. Share Avacta Group With A Colleague Link copied to clipboard. Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
